Home › Asset managers › Compare 2025-2026 › American Century vs Charles Schwab
American Century 2025-2026 · Charles Schwab 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 14,033 | 12,345 | 1,588 | 100 | 88.6% | 88.3% |
| Board proposals | 13,138 | 11,577 | 1,486 | 75 | 88.6% | 88.4% |
| E&S shareholder proposals | 154 | 148 | 6 | 0 | 96.1% | 96.1% |
| Other items | 741 | 620 | 96 | 25 | 86.6% | 85.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,688 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | Charles Schwab |
|---|---|---|---|---|---|---|
| ZSCALER, INC. | January 12, 2026 | To vote on a non-binding stockholder proposal requesting the declassification of our board of directors. Shareholder Rights and Defenses |
Other | Against | AGAINST 12 funds |
FOR 8 funds |
| ZURA BIO LIMITED | June 17, 2026 | Adjournment of the Annual General Meeting: To approve, by ordinary resolution, the adjournment of the Annual General Meeting by the chairman thereof to a later date, if necessary, for the purpose of soliciting additional proxies in favor of the foregoing proposals, in the event the Company does not receive the requisite shareholder votes to approve the foregoing proposals. Corporate Governance |
Other | For | AGAINST 1 fund |
FOR 1 fund |
| 1-800-FLOWERS.COM, INC. | December 10, 2025 | To approve an amendment to the 2003 Long Term Incentive and Share Award Plan to increase the authorized shares. Compensation |
Board | For | AGAINST 5 funds |
FOR 6 funds |
| 10X GENOMICS, INC. | June 4, 2026 | A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 7 funds |
| 1ST SOURCE CORPORATION | April 23, 2026 | Approval of Amended 1982 Restricted Stock Award Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| 1ST SOURCE CORPORATION | April 23, 2026 | Approval of Amended Strategic Deployment Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| 1ST SOURCE CORPORATION | April 23, 2026 | Election of Directors for terms expiring April 2029: Timothy K. Ozark Director Elections |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| 1ST SOURCE CORPORATION | April 23, 2026 | Election of Directors for terms expiring April 2029: Todd F. Schurz Director Elections |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| 3D SYSTEMS CORPORATION | May 14, 2026 | The approval of the amendment and restatement of the 2015 Incentive Plan to increase the number of shares reserved for issuance thereunder by 4,000,000 shares and to extend the term until 2036. Compensation |
Board | For | AGAINST 1 fund |
FOR 4 funds |
| 4D MOLECULAR THERAPEUTICS, INC. | June 17, 2026 | Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers (''say-on-pay vote''). Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 5 funds |
| 908 DEVICES INC | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| A10 NETWORKS, INC. | April 22, 2026 | To approve, on an advisory and non-binding basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 5 funds |
| AAR CORP. | September 16, 2025 | Advisory proposal to approve our Fiscal Year 2025 executive compensation Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 8 funds |
| ABEONA THERAPEUTICS INC. | June 12, 2026 | To approve an increase in the number of shares reserved for issuance under the Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan from 8,400,000 to 11,500,000. Compensation |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| ABEONA THERAPEUTICS INC. | June 12, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| ACADIA HEALTHCARE COMPANY, INC. | May 6, 2026 | Approve a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 8 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares. Compensation |
Board | For | AGAINST 6 funds |
FOR 5 funds |
| ACADIA PHARMACEUTICALS INC. | May 29, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 6 funds |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Approval of 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 8 funds |
| ACADIAN ASSET MANAGEMENT INC. | June 11, 2026 | Election of Directors: Andrew Kim Director Elections |
Board | For | FOR 7 funds |
AGAINST 8 funds |
| ACCENDRA HEALTH, INC. | May 14, 2026 | Non-Binding advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 8 funds |
| ACCENTURE PLC | January 28, 2026 | To approve the Amended and Restated Accenture plc 2010 Share Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 14 funds |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval of an amendment to the 2022 ACCO Brands Corporation Incentive Plan to increase the number of shares available for future grant and eliminate fungible share counting provisions with respect to new awards. Compensation |
Board | For | AGAINST 7 funds |
FOR 7 funds |
| ACCO BRANDS CORPORATION | May 19, 2026 | Approval, by non-binding advisory vote, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 8 funds |
| ACM Research, Inc. | June 10, 2026 | Election of Directors: David H. Wang Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 5 funds |
| ACM Research, Inc. | June 10, 2026 | Election of Directors: Tracy Liu Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 5 funds |
| ACME UNITED CORPORATION | April 27, 2026 | Approval of an amendment to the 2022 Employee Stock Option Plan to increase the number of shares authorized for issuance as described in the Proxy Statement. Compensation |
Board | For | AGAINST 5 funds |
FOR 2 funds |
| ACME UNITED CORPORATION | April 27, 2026 | Approval, by non-binding advisory vote, of the compensation of the named executive officers of the Company as described in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 3 funds |
| ADAPTHEALTH CORP. | June 18, 2026 | Say-on-Pay - Non-binding advisory vote to approve the compensation paid to AdaptHealth's named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 8 funds |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 6 funds |
| ADT Inc. | May 27, 2026 | Election of Directors To be elected for terms expiring in 2027: Danielle Tiedt Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 13 funds |
| ADTALEM GLOBAL EDUCATION INC. | November 12, 2025 | Say-on-pay: Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 10 funds |
| ADTRAN Holdings, Inc. | July 24, 2025 | Election of Directors: Balan Nair Director Elections |
Board | For | FOR 5 funds |
AGAINST 5 funds |
| AEHR TEST SYSTEMS | October 20, 2025 | Proposal to approve an amendment to the Company's 2023 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by an additional 2,500,000 shares of common stock Compensation |
Board | For | AGAINST 1 fund |
FOR 4 funds |
| AEHR TEST SYSTEMS | October 20, 2025 | Proposal to approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| AEROVIRONMENT, INC. | September 25, 2025 | Management proposal to approve the amendment and restatement of the company's 2021 equity incentive plan Compensation |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| AERSALE CORPORATION | June 11, 2026 | Approval of the redomestication of the Company from Delaware to Texas by conversion. Extraordinary Transactions |
Board | For | AGAINST 7 funds |
FOR 2 funds |
| AERSALE CORPORATION | June 11, 2026 | Approval, on an advisory basis, of the Company's named executive officer compensation. Compensation |
Board | For | AGAINST 8 funds |
FOR 3 funds |
| AES CORP | April 29, 2026 | Approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 15 funds |
| AFFIRM HOLDINGS, INC. | December 15, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 10 funds |
| AGILYSYS, INC. | September 4, 2025 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers set forth in the attached Proxy Statement Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 5 funds |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. Compensation |
Board | For | AGAINST 6 funds |
FOR 4 funds |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To vote, on an advisory basis, to approve the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| AIR LEASE CORPORATION | December 18, 2025 | Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the named executive officers of Air Lease Corporation in connection with the merger (the ''Compensation Proposal''). Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 12 funds |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | Election of Directors: Janaki Akella Director Elections |
Board | For | FOR 10 funds |
AGAINST 14 funds |
| ALARM.COM HOLDINGS, INC. | June 3, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 9 funds |
| ALEXANDER & BALDWIN, INC. | March 9, 2026 | To consider and vote on a proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers that is based on or otherwise relates to the merger. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 10 funds |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | Advisory Vote to Approve the Compensation of our Named Executive Officers Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 15 funds |
| ALLOGENE THERAPEUTICS, INC. | June 18, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| ALPHABET INC. | June 5, 2026 | Advisory vote to approve compensation awarded to named executive officers Say-on-Pay |
Board | For | FOR 26 funds |
AGAINST 19 funds |
| ALPHATEC HOLDINGS, INC. | June 10, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 6 funds |
| ALTA EQUIPMENT GROUP INC. | May 29, 2026 | To approve the First Amendment to Alta Equipment Group, Inc 2020 Omnibus Incentive Plan Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| AMC GLOBAL MEDIA INC. | June 16, 2026 | Vote on Proposal to Approve the Company's Amended and Restated 2011 Stock Plan for Non-Employee Directors Compensation |
Board | For | AGAINST 7 funds |
FOR 8 funds |
| AMENTUM HOLDINGS, INC | February 6, 2026 | Advisory vote to approve the Company's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 12 funds |
| AMERESCO, INC. (AMRC) | June 4, 2026 | To approve on a non-binding advisory basis the compensation of our named executive officer as described in the Ameresco, Inc. Proxy Statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 5 funds |
| AMERICA'S CAR-MART, INC. | September 25, 2025 | To approve an advisory resolution regarding the Company's compensation of its named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 8 funds |
| AMERICAN AIRLINES GROUP INC. | June 10, 2026 | A proposal to approve the Amended and Restated 2023 Incentive Award Plan Compensation |
Board | For | AGAINST 2 funds |
FOR 13 funds |
| AMERICAN STATES WATER COMPANY | May 19, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 8 funds |
| AMERICAN STATES WATER COMPANY | May 19, 2026 | To approve the 2026 Stock Incentive Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 7 funds |
| AMERICAN SUPERCONDUCTOR CORPORATION | July 25, 2025 | To approve, on an advisory basis, the compensation of AMSC's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| AMERICAN TOWER CORPORATION | May 20, 2026 | To approve the American Tower Corporation 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 15 funds |
| AMERICAN VANGUARD CORPORATION | July 2, 2025 | Resolved, that the compensation paid to the Company's named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion, is hereby approved. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 2 funds |
| AMERICAN WELL CORP (AMWELL) | June 16, 2026 | To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in executive compensation and the related compensation tables and narrative disclosure in the Company's proxy statement Say-on-Pay |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| AMERICAN WOODMARK CORPORATION | August 21, 2025 | To approve on an advisory basis the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 8 funds |
| AMERICAN WOODMARK CORPORATION | October 30, 2025 | To approve, on an advisory (non-binding) basis, the compensation that will or may be paid to American Woodmark's named executive officers in connection with the transactions contemplated by the merger agreement; and Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 8 funds |
| AMICUS THERAPEUTICS, INC. | March 3, 2026 | To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| AMN HEALTHCARE SERVICES, INC. | May 1, 2026 | To approve, by non-binding advisory vote, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 8 funds |
| AMPHASTAR PHARMACEUTICALS INC. | June 1, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 5 funds |
| AMPLITUDE, INC. | June 9, 2026 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 4 funds |
| AMREP CORPORATION | September 11, 2025 | Approval, on an advisory basis, of the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 6 funds |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 7 funds |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 5 funds |
| ANIKA THERAPEUTICS, INC. | June 18, 2026 | Approval of the Amendment to the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 4 funds |
| ANNEXON, INC. | June 11, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| ANTERIX INC. | August 5, 2025 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 5 funds |
| AON PLC | June 26, 2026 | Advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 15 funds |
| APA CORPORATION | May 21, 2026 | Advisory vote to approve the compensation of APA's named executive officers Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 17 funds |
| APOGEE ENTERPRISES, INC. | June 24, 2026 | APPROVAL OF THE APOGEE ENTERPRISES, INC. 2019 STOCK INCENTIVE PLAN, AS AMENDED AND RESTATED (2026) TO INCREASE THE NUMBER OF SHARES AUTHORIZED FOR AWARDS FROM 2,150,000 TO 2,950,000. Compensation |
Board | For | AGAINST 10 funds |
FOR 7 funds |
| APOGEE THERAPEUTICS, INC. | June 9, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 6 funds |
| APPFOLIO, INC. | June 12, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 8 funds |
| APPLIED INDUSTRIAL TECHNOLOGIES, INC. | October 21, 2025 | Election of Directors: Mary Dean Hall Director Elections |
Board | For | FOR 13 funds |
WITHHOLD 12 funds |
| AQUESTIVE THERAPEUTICS, INC. | June 10, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| ARCHER AVIATION INC. | June 26, 2026 | Approval of the redomestication of the Company from Delaware to Texas by conversion. Extraordinary Transactions |
Board | For | AGAINST 1 fund |
FOR 6 funds |
| ARCTURUS THERAPEUTICS, HOLDINGS INC. | June 5, 2026 | Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 6 funds |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
AGAINST 5 funds |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected. Patrick J. Heron Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 5 funds |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| ARDELYX, INC | June 16, 2026 | To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. Compensation |
Board | For | AGAINST 1 fund |
FOR 5 funds |
| ARDELYX, INC | June 16, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission (''Say-on-Pay''); Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 6 funds |
| ARLO TECHNOLOGIES, INC. | June 18, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 6 funds |
| ARMOUR RESIDENTIAL REIT, INC. | April 30, 2026 | To approve ARMOUR's Fourth Amended and Restated 2009 Stock Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 4 funds |
| ARRAY DIGITAL INFRASTRUCTURE, INC. | October 9, 2025 | Election of Directors: E. C. Iriarte Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 6 funds |
| ARRAY DIGITAL INFRASTRUCTURE, INC. | October 9, 2025 | Election of Directors: X. D. Williams Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 6 funds |
| ARRAY DIGITAL INFRASTRUCTURE, INC. | May 19, 2026 | Election of Directors: E. C. Iriarte Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 6 funds |
| ARRAY DIGITAL INFRASTRUCTURE, INC. | May 19, 2026 | Election of Directors: X. D. Williams Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 6 funds |
| ARRAY TECHNOLOGIES, INC. | May 19, 2026 | Approval, on an advisory basis, of our named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 6 funds |
| ARROWHEAD PHARMACEUTICALS, INC. | March 19, 2026 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 6 funds |
| ARS PHARMACEUTICALS, INC. | June 24, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
← Previous Page 2 of 17 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.